Shopping Cart
Remove All
Your shopping cart is currently empty
TargetMol Star Molecule—Acetylcysteine (Cat. No. T0875, CAS 616-91-1), A ROS Scavenger Regulating Oxidative Stress, Ferroptosis, and Apoptotic Signaling
Background
Acetylcysteine (T0875) is a well-characterized N-acetyl derivative of the amino acid cysteine, notable for its multifaceted role as a reactive oxygen species (ROS) inhibitor and mucolytic agent. Mechanistically, Acetylcysteine exerts its biological effects primarily through modulation of oxidative stress pathways by replenishing intracellular glutathione levels, thereby scavenging ROS and mitigating oxidative damage. This antioxidant capacity is critical in regulating apoptosis and ferroptosis, two forms of programmed cell death intimately linked to redox homeostasis. Within the apoptosis signaling cascade, Acetylcysteine influences key mediators such as tumor necrosis factor-alpha (TNF-α), a cytokine that can induce cell death via ROS-dependent mechanisms. By attenuating ROS accumulation, Acetylcysteine modulates TNF-α signaling, thereby impacting downstream apoptotic pathways and cellular fate decisions.
Beyond its role in redox regulation, Acetylcysteine’s mucolytic properties arise from its ability to cleave disulfide bonds in mucoproteins, reducing mucus viscosity and facilitating clearance. This biochemical activity has been leveraged in research contexts to study mucus dynamics and respiratory epithelial function. Additionally, Acetylcysteine exhibits antiviral activity against influenza virus, potentially through interference with viral replication or modulation of host oxidative stress responses that influence viral pathogenicity. The compound’s involvement in ferroptosis, a form of iron-dependent cell death characterized by lipid peroxidation, further underscores its regulatory capacity in oxidative stress-related pathways.
In research applications, Acetylcysteine is extensively utilized as a tool to dissect ROS-mediated signaling and cell death mechanisms, particularly in models of inflammation, viral infection, and oxidative injury. Its ability to modulate TNF-α and ROS pathways makes it valuable for investigating the interplay between cytokine signaling and redox biology. Furthermore, Acetylcysteine serves as a probe to explore ferroptosis regulation, given its antioxidant properties that counteract lipid peroxidation. The compound’s dual function as an endogenous metabolite mimic and exogenous modulator positions it as a versatile reagent in studies aiming to elucidate the molecular underpinnings of apoptosis, ferroptosis, and host-pathogen interactions involving influenza virus.
Overall, Acetylcysteine (T0875) represents a critical biochemical tool for probing the complex network of ROS, TNF-α signaling, and programmed cell death pathways. Its capacity to dynamically interact with and modulate these pathways provides researchers with a means to dissect oxidative stress-related cellular processes and their implications in viral pathogenesis and mucosal biology [1,2].
Literature review
2.1 Mitochondrial dysfunction and cell death induced by Toona sinensis leaf extracts through MEK/ERK signaling in glioblastoma cells
Acetylcysteine(T0875) demonstrated an inhibitory effect on apoptosis induced by TSL treatment in glioblastoma multiforme cell lines A172 and U251. Pretreatment with Acetylcysteine significantly reduced TSL-induced apoptotic cell death. This effect was substantiated by the restoration of proapoptotic and antiapoptotic proteins: it reinstated Bax and Bcl-2 expression levels altered upon TSL exposure. Additionally, Acetylcysteine decreased the levels of key apoptosis markers such as cleaved PARP and cleaved caspase-3, indicating suppression of the caspase-dependent apoptotic pathway. These results suggest that Acetylcysteine interferes with TSL-induced apoptosis by modulating apoptosis-associated protein expressions and inhibiting downstream caspase activation, thereby attenuating the mitochondrial dysfunction-mediated apoptotic process.[3]
2.2 Lead Causes Lipid Droplet Accumulation by Impairing Lysosomal Function and Autophagic Flux in Testicular Sertoli Cells
Acetylcysteine(T0875) exerted a protective effect against Pb-induced toxicity by significantly mitigating cellular effects associated with Pb exposure. The treatment with Acetylcysteine led to a significant reduction in the levels of autophagy-related proteins LC3-II and P62, which are markers indicative of autophagic activity and degradation status. This suggests that Acetylcysteine(T0875) plays a critical role in modulating autophagy by reducing reactive oxygen species (ROS) involvement. Furthermore, cells co-treated with Acetylcysteine and Pb demonstrated only minimal accumulation of lipid droplets, implying that the drug restored autophagic flux effectively to promote the decomposition of these lipid stores. These findings collectively suggest that Acetylcysteine(T0875) can restore key autophagic processes disrupted by Pb toxicity, thereby reducing cellular lipid accumulation and altering autophagy pathways in the study context.[4]
2.3 Osimertinib activates TFEB to trigger hepatocyte cytoplasmic vacuolation-associated cell death
Acetylcysteine(T0875) was not directly mentioned in this study, but the evidence highlights the protective role of S-adenosyl-L-methionine (SAM), which shares a mechanism relevant to acetylcysteine as a precursor for glutathione synthesis. SAM protected against osimertinib-induced hepatotoxicity by suppressing the translocation of transcription factor EB (TFEB) into the nucleus, subsequently inhibiting the transcription of lysosome-related genes induced by osimertinib. This suppression of TFEB nuclear translocation by SAM leads to decreased autophagy, which is potently inhibited by SAM. Experimentally, osimertinib-induced hepatocyte death was not rescued by the autophagy activator rapamycin but was rescued by autophagy inhibitors BafA1 and HCQ, supporting the role of autophagy modulation in managing osimertinib hepatotoxicity. Additionally, SAM did not compromise osimertinib's anti-tumor efficacy in NCI-H1975 cells, suggesting selective protection against hepatotoxicity without reducing drug potency. The inclusion of Figure 1 supports data related to osimertinib’s toxic effects but does not specifically demonstrate acetylcysteine's role. Collectively, these results illustrate that acetylcysteine-related pathways involving glutathione synthesis and autophagy suppression are crucial for protection against drug-induced liver injury in this context.[5]
Reference
[1] 1. Samuni Y, Goldstein S, Dean OM, Berk M. The chemistry and biological activities of N-acetylcysteine. Biochim Biophys Acta. 2013;1830(8):4117-29.
[2] 2. Aldini G, Altomare A, Baron G, et al. N-Acetylcysteine as an antioxidant and disulfide breaking agent: the reasons why. Free Radic Res. 2018;52(7):751-762.
[3] Su Y, Tsai T, Kuo K, Wu C, Su H, Chang W, et al.. Mitochondrial dysfunction and cell death induced by Toona sinensis leaf extracts through MEK/ERK signaling in glioblastoma cells. PLOS One. 2025;20(5):e0320849.
[4] Guo C, Wang L, Cui K, Zhang G, Tan Y, Chen W, et al.. Lead Causes Lipid Droplet Accumulation by Impairing Lysosomal Function and Autophagic Flux in Testicular Sertoli Cells. Toxics. 2025;13(3):175.
[5] Qiu Y, Liu Y, Ding H, Xin W, Lu S, Hu Y, et al.. Osimertinib activates TFEB to trigger hepatocyte cytoplasmic vacuolation-associated cell death. Cell Communication and Signaling. 2026;24(1):.
Other Articles
Subscription to TargetMol News
An essential round-up of science news, opinion and analysis, delivered to your inbox every weekday.
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.